Principal Accounting Officer Barton Shane bought 2,632 shares of BIOA at $18.00 (first position); stock now $4.33, -83.2% from 52-week high.
Barton Shane, serving as Principal Accounting Officer, purchased 2,632 shares at $18.00 on 2024-09-27, establishing his first recorded position in BioAge Labs. The timing is notable: the purchase price of $18.00 was significantly closer to the 52-week high of $25.83 than to today's current price of $4.33, representing a -83.2% decline from the 52-week peak. The company is currently unprofitable with net income of -$23.4M against a market cap of $155.2M, indicating substantial operational losses. The sharp gap between the insider's entry price and the current valuation warrants attention to whether fundamental deterioration occurred post-purchase or whether market conditions shifted materially after the transaction date.